Traditional and complementary medicine during COVID-19 pandemic.
作者信息
Ganguly Shuvadeep, Bakhshi Sameer
机构信息
Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Phytother Res. 2020 Dec;34(12):3083-3084. doi: 10.1002/ptr.6828. Epub 2020 Aug 12.
Abstract
摘要
相似文献
1
Traditional and complementary medicine during COVID-19 pandemic.新冠疫情期间的传统医学与补充替代医学
Phytother Res. 2020 Dec;34(12):3083-3084. doi: 10.1002/ptr.6828. Epub 2020 Aug 12.
2
Complementary and alternative medicine during COVID-19 pandemic: What we have done.2019冠状病毒病大流行期间的补充和替代医学：我们所做的工作。
J Integr Med. 2022 Jan;20(1):1-3. doi: 10.1016/j.joim.2021.11.008. Epub 2021 Nov 27.
3
Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope.补充和替代医学在 COVID-19 预防和治疗中的作用：一个被过度炒作的希望。
Chin J Integr Med. 2020 Aug;26(8):565-567. doi: 10.1007/s11655-020-2851-y. Epub 2020 Aug 5.
4
Integrative considerations during the COVID-19 pandemic.2019冠状病毒病大流行期间的综合考量
Explore (NY). 2020 Nov-Dec;16(6):354-356. doi: 10.1016/j.explore.2020.03.007. Epub 2020 Mar 26.
5
Complementary Study.补充研究。
Dtsch Arztebl Int. 2021 Mar 12;118(10):179. doi: 10.3238/arztebl.m2021.0038.
6
Medical Toxicology and COVID-19: Our Role in a Pandemic.医学毒理学与2019冠状病毒病：我们在大流行中的作用。
J Med Toxicol. 2020 Jul;16(3):245-247. doi: 10.1007/s13181-020-00778-4. Epub 2020 Apr 30.
7
Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran.在 COVID-19 疫情期间普通人群中对补充和替代医学的使用：伊朗的一项调查。
J Integr Med. 2022 Jan;20(1):45-51. doi: 10.1016/j.joim.2021.11.004. Epub 2021 Nov 16.
8
[Occurrence of physical and mental disorders among Vietnamese technical intern trainees during the COVID-19 pandemic and current status of correspondence].
Sangyo Eiseigaku Zasshi. 2022 Jan 25;64(1):22-25. doi: 10.1539/sangyoeisei.2020-048-D. Epub 2021 Feb 5.
9
Prevalence and predictive factors of complementary medicine use during the first wave of the COVID-19 pandemic of 2020 in the Netherlands.2020 年 COVID-19 大流行第一波期间荷兰补充医学的使用情况及预测因素。
BMC Complement Med Ther. 2022 Feb 15;22(1):43. doi: 10.1186/s12906-022-03528-x.
10
Complementary and alternative medicine therapies and COVID-19: a systematic review.补充和替代医学疗法与 COVID-19：系统评价。
Rev Environ Health. 2021 Apr 12;36(3):443-450. doi: 10.1515/reveh-2021-0012. Print 2021 Sep 27.
引用本文的文献
1
Unique Challenges in the Management of Retinoblastoma in India - Need for Country-Specific Guidelines.印度视网膜母细胞瘤管理中的独特挑战——制定针对该国的指南的必要性。
Indian J Pediatr. 2024 Nov;91(11):1145-1146. doi: 10.1007/s12098-024-05184-0. Epub 2024 Jun 4.
2
Safety and Efficacy of the Ayurvedic Formulation Guduchi Ghana Vati as a Preventive Remedy in COVID-19.印度草医学配方古杜奇加纳瓦蒂作为COVID-19预防药物的安全性和有效性
Cureus. 2024 Apr 23;16(4):e58807. doi: 10.7759/cureus.58807. eCollection 2024 Apr.
3
Treating Pediatric Acute Promyelocytic Leukemia in India - Key Challenges and Lessons Learned.
Indian J Pediatr. 2024 Jun;91(6):535-536. doi: 10.1007/s12098-023-05014-9. Epub 2023 Dec 30.
4
Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage?著名的阿育吠陀保肝药匙羹藤（心叶宽筋藤）会导致肝损伤吗？
J Ayurveda Integr Med. 2023 Jan-Feb;14(1):100658. doi: 10.1016/j.jaim.2022.100658. Epub 2022 Nov 16.
5
Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19.COVID-19 患者中补充和整合医学的使用情况及相关因素。
BMC Complement Med Ther. 2022 Sep 30;22(1):251. doi: 10.1186/s12906-022-03722-x.
6
Reinterpretation of Health Information in the Context of an Emerging Infectious Disease: A Digital Focus Group Study.在新发传染病背景下对健康信息的重新解读：一项数字焦点小组研究
JMIR Hum Factors. 2022 Nov 22;9(4):e39312. doi: 10.2196/39312.
7
Consumption of Herbal Supplements or Homeopathic Remedies to Prevent COVID-19 and Intention of Vaccination for COVID-19 in Latin America and the Caribbean.拉丁美洲和加勒比地区使用草药补充剂或顺势疗法药物预防新冠病毒的情况以及新冠病毒疫苗接种意愿
Trop Med Infect Dis. 2022 Jun 8;7(6):95. doi: 10.3390/tropicalmed7060095.
8
Complementary and alternative medicine (CAM) interventions for COVID-19: An overview of systematic reviews.用于治疗新型冠状病毒肺炎的补充和替代医学干预措施：系统评价综述
Integr Med Res. 2022 Sep;11(3):100842. doi: 10.1016/j.imr.2022.100842. Epub 2022 Mar 13.
9
Phytocompounds and COVID-19: Two years of knowledge.植物化合物与新冠疫情：两年的知识积累
Phytother Res. 2022 Jun;36(6):2267-2271. doi: 10.1002/ptr.7420. Epub 2022 Feb 16.
10
Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.植物药在 COVID-19 住院患者凝血功能障碍管理中的潜在临床应用。
Phytother Res. 2022 May;36(5):1884-1913. doi: 10.1002/ptr.7408. Epub 2022 Feb 11.
本文引用的文献
1
Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis.中西医结合治疗 2019 年冠状病毒病（COVID-19）的疗效和安全性：系统评价和荟萃分析。
Pharmacol Res. 2020 Aug;158:104896. doi: 10.1016/j.phrs.2020.104896. Epub 2020 May 11.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies.中药疗效、不良反应和药物相互作用的临床评估方法。
Phytother Res. 2016 May;30(5):691-700. doi: 10.1002/ptr.5591. Epub 2016 Feb 17.
4
Broad-spectrum antivirals against viral fusion.针对病毒融合的广谱抗病毒药物。
Nat Rev Microbiol. 2015 Jul;13(7):426-37. doi: 10.1038/nrmicro3475. Epub 2015 Jun 15.
Zotero 插件